MiMedx Group, Inc.
MDXG
$6.68
$0.050.75%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 8.52% | 10.93% | 15.41% | 19.20% | 20.03% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.52% | 10.93% | 15.41% | 19.20% | 20.03% |
| Cost of Revenue | 9.96% | 3.34% | 7.45% | 8.67% | 13.08% |
| Gross Profit | 8.23% | 12.58% | 17.14% | 21.53% | 21.55% |
| SG&A Expenses | 0.04% | -2.09% | -4.60% | -3.93% | -2.06% |
| Depreciation & Amortization | 0.13% | 1.33% | 3.12% | 5.83% | 8.69% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.83% | 1.11% | -1.12% | -0.90% | 0.64% |
| Operating Income | 59.81% | 93.27% | 330.52% | 979.07% | 351.99% |
| Income Before Tax | 87.04% | 125.60% | 560.94% | 491.83% | 255.12% |
| Income Tax Expenses | 141.55% | -4,444.13% | -49,825.86% | -17,888.66% | -17,967.48% |
| Earnings from Continuing Operations | -37.72% | 230.43% | 896.35% | 787.73% | 437.99% |
| Earnings from Discontinued Operations | 104.57% | 122.89% | 118.80% | -96.32% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.15% | 1,939.61% | 804.25% | 393.52% | 292.83% |
| EBIT | 59.81% | 93.27% | 330.52% | 979.07% | 351.99% |
| EBITDA | 61.20% | 85.12% | 262.87% | 3,052.68% | 479.52% |
| EPS Basic | -25.83% | 2,871.49% | 473.69% | 285.04% | 219.39% |
| Normalized Basic EPS | 50.83% | 86.34% | 463.20% | 462.58% | 248.86% |
| EPS Diluted | -23.25% | 4,401.45% | 472.57% | 274.37% | 211.07% |
| Normalized Diluted EPS | 90.78% | 105.60% | 545.36% | 402.29% | 216.10% |
| Average Basic Shares Outstanding | 26.13% | 21.89% | 15.94% | 9.77% | 3.35% |
| Average Diluted Shares Outstanding | 6.69% | 13.63% | 22.39% | 31.11% | 24.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |